JSA has advised Rx Propellant in relation to its acquisition and investment of USD 200 million by Actis, a london-headquartered global investor.
Rx Propellant is a platform operating in the life sciences real estate sector focused in Hyderabad, Bengaluru and Mumbai regions.
Deal Value: USD 200 million.
JSA team comprised Partner – Rajeev Reddy and Senior Associate – Garima Sharma.